News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
PDL BioPharma, Inc. (JOBS) Swings To $55.7M Q3 Profit
November 7, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Silicon Valley / San Jose Business Journal -- PDL BioPharma Inc. on Thursday reported third quarter net income of $55.7 million, or 38 cents a share, compared to a loss in the same period last year of $5.8 million, or 5 cents a share.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Podcast
Q3 earnings roll on, FDA pushes rare disease, uniQure’s Huntington’s therapy reaches review
November 4, 2026
·
1 min read
·
Jef Akst
Earnings
Pfizer, fresh to China’s obesity market, looks to Viagra model to compete
November 3, 2026
·
3 min read
·
Annalee Armstrong
Psychedelics
Compass to submit psilocybin depression drug for approval imminently after stock wobbles
November 3, 2026
·
2 min read
·
Heather McKenzie
Rare diseases
Neurocrine defends Prader-Willi drug after another patient death
November 3, 2026
·
3 min read
·
Annalee Armstrong
